THRX 외환 뉴스
Theseus Pharma To Acquire Concentra Biosciences For $4.05/Shr In Cash
Biopharmaceutical company Theseus Pharmaceuticals, Inc. (THRX) announced Friday it has entered into a definitive merger agreement whereby Concentra Biosciences, LLC will acquire Theseus for a price per share of Theseus common stock of between $3.90 and $4.05 in cash.
RTTNews
|
1013 일 전
